0
Laboratory and Animal Investigations |

Effects of Nebulized Diethylenetetraamine-NONOate in a Mouse Model of Acute Pseudomonas aeruginosa Pneumonia*

Adam M. Dukelow, BSc; Sean Weicker, MSc; Tim A. Karachi, MD; Habib M. Razavi, MSc; David G. McCormack, MD; Mariamma G. Joseph, MD; Sanjay Mehta, MD
Author and Funding Information

*From the A.C. Burton Vascular Biology Group (Mr. Dukelow), Lawson Health Research Institute, Respirology Division, London Health Sciences Center, London, ON, Canada; and the Departments of Medicine (Drs. Karachi, McCormack, and Mehta), Pathology (Dr. Joseph), and Pharmacology/Toxicology (Mr. Weicker and Mr. Razavi), University of Western Ontario, London, ON, Canada.

Correspondence to: Sanjay Mehta, MD, Respirology Division, London Health Sciences Center-Victoria South Street Campus, 375 South St, London, ON, Canada N6A 4G5; e-mail: sanjay.mehta@lhsc.on.ca



Chest. 2002;122(6):2127-2136. doi:10.1378/chest.122.6.2127
Text Size: A A A
Published online

Objective: Endogenous and exogenous nitric oxide (NO) may have important antibacterial effects in patients with pneumonia. NO administration has been limited to the continuous inhalation of gas-phase NO (ie, inhaled NO [iNO]). Intermittent nebulization of NONOates, novel NO donors, may permit the continuous intrapulmonary delivery of NO. Thus, we assessed the effects of nebulized diethylenetetraamine-NONOate (DETA-NO) in a model of acute Pseudomonas aeruginosa pneumonia.

Design: Randomized, controlled study.

Subjects: Male C57Bl/6 mice.

Interventions: Pneumonia was induced by intratracheal instillation of P aeruginosa (3 × 107 CFU in 50 μL). Pneumonia and sham mice were randomized to receive no treatment, nebulized DETA-NO (12.5 or 125 μmol) at 4 h and 12 h, or continuous iNO for 24 h (10 or 40 ppm) until they were killed at 24 h.

Main results: The nebulization of DETA-NO was associated with a marked increase in mean (± SEM) exhaled NO levels (after nebulization, 484 ± 34 parts per billion [ppb]; baseline, 13.4 ± 0.4 ppb; p < 0.01) and plasma levels of nitrites/nitrates (after nebulization, 73 ± 28 μM; at baseline, 14 ± 3 μM; p < 0.05). Nebulized DETA-NO decreased the pulmonary bacterial load in mice with pneumonia by 65 ± 19% (p < 0.05 vs untreated mice) but had no effect on pulmonary leukocyte infiltration. Although the growth of P aeruginosa colonies in vitro was impaired on exposure to DETA-NO, growth was similarly impaired by exposure to DETA nucleophile/backbone alone.

Conclusions: The nebulization of DETA-NO provides a method for the prolonged intrapulmonary delivery of NO. The antibacterial effect of DETA-NO in vivo and in vitro is due, in large part, to the DETA nucleophile moiety and is independent of NO, suggesting a limited therapeutic role for exogenous NO in pneumonia.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543